Testing effectiveness (Phase 2)Ended earlyNCT04191382
What this trial is testing
Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer
Who this might be right for
Breast Cancer
Sanofi 105